Sphera Biotech US Fund, L.P. — Form D/A

Sphera Biotech US Fund, L.P. of TEL AVIV, L3, a pooled investment fund, filed a Form D amendment with the SEC on 2024-04-16. $31.8M was reported sold. Industry: Pooled Investment Fund.

Offering

• Filed: 2024-04-16
• Form: D/A
• Accession: 0001749475-24-000001
• Industry: Pooled Investment Fund
• Exemptions: 06b, 3C, 3C.7
• Amount sold: $31.8M
• Minimum investment: $500K
• Investors: 10
• Date of first sale: 2018-10-01
• Security types: fund interests
• SEC file number: 021-323124

Issuer

• Name: Sphera Biotech US Fund, L.P.
• CIK: 0001749475
• Entity type: Limited Partnership
• Jurisdiction: DELAWARE
• Incorporated: 2018
• Address: SPHERA GLOBAL HEALTHCARE MANAGEMENT, LP TOU-TOWERS, YITZHAK SADEH 4, TEL AVIV, L3, 6777520
• Phone: 972-3-6845535

Officers, directors & promoters (12)

Other filings by this issuer (8)

More

• CIK 1749475 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search